Puerto Rico

Puerto Rico

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.4 (0.34 - 0.46) 2019 Modelled IHME
0.4 (0.34 - 0.46) 2018 Modelled IHME
0.4 (0.33 - 0.46) 2017 Modelled IHME
0.4 (0.34 - 0.46) 2016 Modelled IHME
0.41 (0.34 - 0.47) 2015 Modelled IHME
0.42 (0.35 - 0.48) 2014 Modelled IHME
0.43 (0.36 - 0.49) 2013 Modelled IHME
0.44 (0.37 - 0.49) 2012 Modelled IHME
0.44 (0.37 - 0.51) 2011 Modelled IHME
0.45 (0.38 - 0.52) 2010 Modelled IHME
0.46 (0.38 - 0.53) 2009 Modelled IHME
0.47 (0.39 - 0.53) 2008 Modelled IHME
0.47 (0.39 - 0.54) 2007 Modelled IHME
0.48 (0.40 - 0.55) 2006 Modelled IHME
0.48 (0.40 - 0.56) 2005 Modelled IHME
0.49 (0.41 - 0.56) 2004 Modelled IHME
0.49 (0.41 - 0.57) 2003 Modelled IHME
0.49 (0.42 - 0.57) 2002 Modelled IHME
0.5 (0.42 - 0.57) 2001 Modelled IHME
0.5 (0.42 - 0.58) 2000 Modelled IHME
0.51 (0.43 - 0.59) 1999 Modelled IHME
0.52 (0.44 - 0.60) 1998 Modelled IHME
0.53 (0.45 - 0.61) 1997 Modelled IHME
0.54 (0.45 - 0.62) 1996 Modelled IHME
0.54 (0.45 - 0.63) 1995 Modelled IHME
0.55 (0.45 - 0.64) 1994 Modelled IHME
0.56 (0.46 - 0.65) 1993 Modelled IHME
0.56 (0.46 - 0.65) 1992 Modelled IHME
0.57 (0.46 - 0.66) 1991 Modelled IHME
0.57 (0.46 - 0.68) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.04 (0.03 - 0.05) 2019 Modelled IHME
0.04 (0.03 - 0.05) 2018 Modelled IHME
0.04 (0.02 - 0.05) 2017 Modelled IHME
0.04 (0.02 - 0.05) 2016 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled IHME
0.04 (0.03 - 0.05) 2014 Modelled IHME
0.04 (0.03 - 0.05) 2013 Modelled IHME
0.04 (0.03 - 0.05) 2012 Modelled IHME
0.04 (0.03 - 0.05) 2011 Modelled IHME
0.04 (0.03 - 0.05) 2010 Modelled IHME
0.04 (0.03 - 0.06) 2009 Modelled IHME
0.04 (0.03 - 0.06) 2008 Modelled IHME
0.04 (0.03 - 0.06) 2007 Modelled IHME
0.05 (0.03 - 0.06) 2006 Modelled IHME
0.05 (0.03 - 0.07) 2005 Modelled IHME
0.05 (0.03 - 0.07) 2004 Modelled IHME
0.05 (0.04 - 0.07) 2003 Modelled IHME
0.05 (0.04 - 0.07) 2002 Modelled IHME
0.06 (0.04 - 0.08) 2001 Modelled IHME
0.06 (0.04 - 0.08) 2000 Modelled IHME
0.07 (0.05 - 0.08) 1999 Modelled IHME
0.07 (0.05 - 0.09) 1998 Modelled IHME
0.08 (0.05 - 0.10) 1997 Modelled IHME
0.08 (0.06 - 0.11) 1996 Modelled IHME
0.09 (0.06 - 0.12) 1995 Modelled IHME
0.09 (0.07 - 0.13) 1994 Modelled IHME
0.1 (0.07 - 0.13) 1993 Modelled IHME
0.1 (0.07 - 0.14) 1992 Modelled IHME
0.11 (0.08 - 0.15) 1991 Modelled IHME
0.11 (0.08 - 0.15) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
20,580 (16,662 - 24,395) 1990 Modelled IHME
20,630 (16,817 - 24,186) 1991 Modelled IHME
20,649 (17,005 - 24,026) 1992 Modelled IHME
20,641 (17,118 - 23,948) 1993 Modelled IHME
20,606 (17,029 - 23,942) 1994 Modelled IHME
20,545 (17,036 - 23,894) 1995 Modelled IHME
20,414 (17,099 - 23,491) 1996 Modelled IHME
20,203 (17,041 - 23,236) 1997 Modelled IHME
19,951 (16,981 - 22,889) 1998 Modelled IHME
19,706 (16,763 - 22,594) 1999 Modelled IHME
19,512 (16,463 - 22,551) 2000 Modelled IHME
19,358 (16,438 - 22,105) 2001 Modelled IHME
19,204 (16,326 - 22,062) 2002 Modelled IHME
19,045 (16,047 - 21,926) 2003 Modelled IHME
18,867 (15,827 - 21,731) 2004 Modelled IHME
18,655 (15,489 - 21,623) 2005 Modelled IHME
18,406 (15,291 - 21,146) 2006 Modelled IHME
18,132 (15,127 - 20,801) 2007 Modelled IHME
17,834 (14,909 - 20,432) 2008 Modelled IHME
17,517 (14,605 - 20,051) 2009 Modelled IHME
17,187 (14,359 - 19,771) 2010 Modelled IHME
16,826 (14,029 - 19,185) 2011 Modelled IHME
16,432 (13,768 - 18,634) 2012 Modelled IHME
16,026 (13,392 - 18,190) 2013 Modelled IHME
15,626 (12,972 - 17,845) 2014 Modelled IHME
15,256 (12,650 - 17,542) 2015 Modelled IHME
14,858 (12,436 - 16,989) 2016 Modelled IHME
14,398 (11,993 - 16,703) 2017 Modelled IHME
14,147 (11,946 - 16,257) 2018 Modelled IHME
14,173 (12,137 - 16,265) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.06 (2.08 - 4.24) 2019 Modelled IHME
3.06 (2.11 - 4.15) 2018 Modelled IHME
3 (2.25 - 4) 2017 Modelled IHME
2.94 (2.28 - 3.74) 2016 Modelled IHME
2.81 (2.18 - 3.60) 2015 Modelled IHME
2.86 (2.23 - 3.63) 2014 Modelled IHME
2.91 (2.27 - 3.69) 2013 Modelled IHME
2.84 (2.22 - 3.58) 2012 Modelled IHME
2.94 (2.28 - 3.72) 2011 Modelled IHME
2.71 (2.11 - 3.46) 2010 Modelled IHME
2.88 (2.24 - 3.68) 2009 Modelled IHME
2.85 (2.20 - 3.60) 2008 Modelled IHME
2.89 (2.23 - 3.68) 2007 Modelled IHME
2.91 (2.24 - 3.71) 2006 Modelled IHME
2.98 (2.30 - 3.82) 2005 Modelled IHME
3 (2.31 - 3.86) 2004 Modelled IHME
3 (2.29 - 3.83) 2003 Modelled IHME
3.05 (2.35 - 3.92) 2002 Modelled IHME
3.29 (2.53 - 4.18) 2001 Modelled IHME
3.28 (2.51 - 4.22) 2000 Modelled IHME
3.42 (2.60 - 4.38) 1999 Modelled IHME
3.74 (2.83 - 4.82) 1998 Modelled IHME
3.67 (2.80 - 4.73) 1997 Modelled IHME
3.97 (3.01 - 5.09) 1996 Modelled IHME
4.19 (3.22 - 5.35) 1995 Modelled IHME
4.23 (3.26 - 5.38) 1994 Modelled IHME
4.72 (3.68 - 5.98) 1993 Modelled IHME
4.91 (3.81 - 6.17) 1992 Modelled IHME
5.21 (4.09 - 6.54) 1991 Modelled IHME
5.51 (4.31 - 6.94) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
108 (73 - 149) 2019 Modelled IHME
108 (75 - 147) 2018 Modelled IHME
108 (81 - 145) 2017 Modelled IHME
108 (84 - 138) 2016 Modelled IHME
104 (81 - 134) 2015 Modelled IHME
107 (83 - 135) 2014 Modelled IHME
109 (85 - 138) 2013 Modelled IHME
107 (84 - 135) 2012 Modelled IHME
111 (86 - 141) 2011 Modelled IHME
103 (80 - 131) 2010 Modelled IHME
110 (86 - 140) 2009 Modelled IHME
109 (84 - 138) 2008 Modelled IHME
111 (86 - 142) 2007 Modelled IHME
112 (86 - 143) 2006 Modelled IHME
115 (89 - 148) 2005 Modelled IHME
116 (90 - 149) 2004 Modelled IHME
117 (89 - 149) 2003 Modelled IHME
119 (91 - 152) 2002 Modelled IHME
128 (98 - 162) 2001 Modelled IHME
127 (97 - 164) 2000 Modelled IHME
132 (100 - 169) 1999 Modelled IHME
144 (109 - 185) 1998 Modelled IHME
140 (107 - 181) 1997 Modelled IHME
151 (114 - 194) 1996 Modelled IHME
158 (121 - 202) 1995 Modelled IHME
158 (122 - 202) 1994 Modelled IHME
175 (137 - 222) 1993 Modelled IHME
181 (140 - 227) 1992 Modelled IHME
190 (149 - 239) 1991 Modelled IHME
199 (156 - 251) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (16 - 30) 2019 Modelled IHME
22 (16 - 31) 2018 Modelled IHME
23 (16 - 31) 2017 Modelled IHME
23 (16 - 32) 2016 Modelled IHME
23 (17 - 32) 2015 Modelled IHME
23 (17 - 33) 2014 Modelled IHME
24 (17 - 33) 2013 Modelled IHME
24 (17 - 33) 2012 Modelled IHME
24 (17 - 33) 2011 Modelled IHME
24 (17 - 33) 2010 Modelled IHME
25 (18 - 33) 2009 Modelled IHME
25 (18 - 33) 2008 Modelled IHME
25 (18 - 33) 2007 Modelled IHME
25 (18 - 34) 2006 Modelled IHME
25 (18 - 34) 2005 Modelled IHME
25 (18 - 34) 2004 Modelled IHME
25 (18 - 34) 2003 Modelled IHME
25 (19 - 34) 2002 Modelled IHME
26 (19 - 34) 2001 Modelled IHME
25 (19 - 34) 2000 Modelled IHME
25 (18 - 34) 1999 Modelled IHME
25 (18 - 34) 1998 Modelled IHME
25 (18 - 33) 1997 Modelled IHME
25 (18 - 33) 1996 Modelled IHME
25 (18 - 33) 1995 Modelled IHME
25 (18 - 33) 1994 Modelled IHME
25 (18 - 34) 1993 Modelled IHME
25 (18 - 34) 1992 Modelled IHME
25 (18 - 34) 1991 Modelled IHME
25 (18 - 34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
15 (10 - 23) 2013 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.06 (1.68 - 2.51) 2019 Modelled IHME
2.04 (1.68 - 2.51) 2018 Modelled IHME
2.03 (1.66 - 2.50) 2017 Modelled IHME
2 (1.64 - 2.44) 2016 Modelled IHME
1.99 (1.62 - 2.42) 2015 Modelled IHME
1.99 (1.62 - 2.42) 2014 Modelled IHME
1.99 (1.62 - 2.43) 2013 Modelled IHME
1.99 (1.62 - 2.43) 2012 Modelled IHME
1.99 (1.62 - 2.44) 2011 Modelled IHME
1.99 (1.62 - 2.45) 2010 Modelled IHME
1.99 (1.63 - 2.45) 2009 Modelled IHME
2.01 (1.64 - 2.47) 2008 Modelled IHME
2.03 (1.65 - 2.48) 2007 Modelled IHME
2.05 (1.67 - 2.50) 2006 Modelled IHME
2.07 (1.69 - 2.54) 2005 Modelled IHME
2.09 (1.71 - 2.56) 2004 Modelled IHME
2.11 (1.73 - 2.59) 2003 Modelled IHME
2.14 (1.74 - 2.63) 2002 Modelled IHME
2.16 (1.76 - 2.66) 2001 Modelled IHME
2.17 (1.76 - 2.68) 2000 Modelled IHME
2.18 (1.78 - 2.67) 1999 Modelled IHME
2.18 (1.77 - 2.67) 1998 Modelled IHME
2.19 (1.77 - 2.68) 1997 Modelled IHME
2.19 (1.78 - 2.69) 1996 Modelled IHME
2.19 (1.78 - 2.68) 1995 Modelled IHME
2.19 (1.78 - 2.68) 1994 Modelled IHME
2.18 (1.77 - 2.68) 1993 Modelled IHME
2.17 (1.77 - 2.67) 1992 Modelled IHME
2.16 (1.76 - 2.67) 1991 Modelled IHME
2.15 (1.75 - 2.65) 1990 Modelled IHME
1 (0.60 - 1.60) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.68 (0.44 - 1.15) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
2.3 (1.30 - 4.20) 2014 Survey/reported Gower et al, 2014
2.3 2019 Modelled Jin et al. 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
78.4 (73.50 - 82.80) 2015 Survey/reported Abadie R et al, 2016
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
4.9 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
77,713 (63,230 - 95,699) 1990 Modelled IHME
78,887 (64,310 - 97,505) 1991 Modelled IHME
79,995 (65,222 - 98,156) 1992 Modelled IHME
81,012 (65,781 - 99,461) 1993 Modelled IHME
81,900 (66,585 - 100,266) 1994 Modelled IHME
82,618 (67,001 - 101,060) 1995 Modelled IHME
83,172 (67,445 - 102,381) 1996 Modelled IHME
83,609 (67,719 - 102,366) 1997 Modelled IHME
83,918 (68,025 - 102,797) 1998 Modelled IHME
84,111 (68,557 - 103,209) 1999 Modelled IHME
84,192 (68,261 - 104,004) 2000 Modelled IHME
83,883 (68,230 - 103,440) 2001 Modelled IHME
83,094 (67,611 - 102,188) 2002 Modelled IHME
82,043 (67,061 - 100,690) 2003 Modelled IHME
80,922 (66,173 - 99,175) 2004 Modelled IHME
79,915 (65,351 - 98,057) 2005 Modelled IHME
78,941 (64,379 - 96,567) 2006 Modelled IHME
77,883 (63,359 - 95,352) 2007 Modelled IHME
76,868 (62,855 - 94,443) 2008 Modelled IHME
76,021 (62,196 - 93,536) 2009 Modelled IHME
75,479 (61,604 - 92,921) 2010 Modelled IHME
75,132 (61,194 - 92,437) 2011 Modelled IHME
74,795 (61,163 - 91,609) 2012 Modelled IHME
74,467 (60,726 - 91,037) 2013 Modelled IHME
74,128 (60,520 - 90,374) 2014 Modelled IHME
73,785 (60,117 - 89,548) 2015 Modelled IHME
73,864 (60,344 - 90,034) 2016 Modelled IHME
73,228 (59,836 - 90,228) 2017 Modelled IHME
72,434 (59,521 - 88,931) 2018 Modelled IHME
72,536 (59,272 - 88,405) 2019 Modelled IHME
36,000 (23,000 - 60,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
4,300 (2,800 - 7,300) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.4 (4.36 - 9) 2019 Modelled IHME
6.31 (4.50 - 8.66) 2018 Modelled IHME
6.1 (4.50 - 8.13) 2017 Modelled IHME
5.91 (4.53 - 7.65) 2016 Modelled IHME
5.57 (4.28 - 7.24) 2015 Modelled IHME
5.68 (4.37 - 7.39) 2014 Modelled IHME
5.73 (4.37 - 7.37) 2013 Modelled IHME
5.54 (4.25 - 7.17) 2012 Modelled IHME
5.74 (4.41 - 7.46) 2011 Modelled IHME
5.24 (4 - 6.79) 2010 Modelled IHME
5.55 (4.25 - 7.30) 2009 Modelled IHME
5.49 (4.24 - 7.14) 2008 Modelled IHME
5.58 (4.30 - 7.34) 2007 Modelled IHME
5.6 (4.31 - 7.29) 2006 Modelled IHME
5.76 (4.40 - 7.52) 2005 Modelled IHME
5.8 (4.42 - 7.58) 2004 Modelled IHME
5.8 (4.48 - 7.60) 2003 Modelled IHME
5.89 (4.56 - 7.69) 2002 Modelled IHME
6.33 (4.88 - 8.25) 2001 Modelled IHME
6.34 (4.91 - 8.19) 2000 Modelled IHME
6.59 (5.10 - 8.55) 1999 Modelled IHME
7.17 (5.51 - 9.36) 1998 Modelled IHME
6.93 (5.37 - 9.05) 1997 Modelled IHME
7.29 (5.65 - 9.46) 1996 Modelled IHME
7.44 (5.81 - 9.72) 1995 Modelled IHME
7.15 (5.60 - 9.26) 1994 Modelled IHME
7.43 (5.86 - 9.52) 1993 Modelled IHME
7.26 (5.75 - 9.27) 1992 Modelled IHME
7.24 (5.74 - 9.24) 1991 Modelled IHME
7.21 (5.69 - 9.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
226 (154 - 317) 2019 Modelled IHME
224 (159 - 307) 2018 Modelled IHME
221 (163 - 294) 2017 Modelled IHME
218 (167 - 282) 2016 Modelled IHME
207 (159 - 268) 2015 Modelled IHME
212 (163 - 276) 2014 Modelled IHME
215 (164 - 276) 2013 Modelled IHME
209 (160 - 270) 2012 Modelled IHME
217 (167 - 282) 2011 Modelled IHME
199 (152 - 258) 2010 Modelled IHME
212 (162 - 279) 2009 Modelled IHME
210 (162 - 273) 2008 Modelled IHME
215 (165 - 282) 2007 Modelled IHME
216 (166 - 281) 2006 Modelled IHME
223 (170 - 291) 2005 Modelled IHME
225 (171 - 294) 2004 Modelled IHME
225 (174 - 295) 2003 Modelled IHME
229 (177 - 299) 2002 Modelled IHME
246 (189 - 320) 2001 Modelled IHME
246 (190 - 317) 2000 Modelled IHME
254 (197 - 330) 1999 Modelled IHME
276 (212 - 360) 1998 Modelled IHME
265 (205 - 346) 1997 Modelled IHME
277 (215 - 359) 1996 Modelled IHME
281 (219 - 367) 1995 Modelled IHME
268 (210 - 347) 1994 Modelled IHME
276 (217 - 353) 1993 Modelled IHME
267 (211 - 341) 1992 Modelled IHME
264 (209 - 337) 1991 Modelled IHME
261 (205 - 332) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
25 (17 - 32) 2019 Modelled IHME
24 (17 - 32) 2018 Modelled IHME
24 (17 - 32) 2017 Modelled IHME
24 (17 - 31) 2016 Modelled IHME
23 (17 - 31) 2015 Modelled IHME
24 (17 - 31) 2014 Modelled IHME
24 (16 - 31) 2013 Modelled IHME
24 (16 - 31) 2012 Modelled IHME
24 (17 - 31) 2011 Modelled IHME
24 (17 - 31) 2010 Modelled IHME
23 (16 - 31) 2009 Modelled IHME
23 (16 - 31) 2008 Modelled IHME
23 (16 - 31) 2007 Modelled IHME
23 (16 - 31) 2006 Modelled IHME
23 (16 - 31) 2005 Modelled IHME
23 (16 - 30) 2004 Modelled IHME
23 (16 - 31) 2003 Modelled IHME
23 (16 - 30) 2002 Modelled IHME
22 (16 - 30) 2001 Modelled IHME
23 (16 - 30) 2000 Modelled IHME
23 (16 - 30) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (17 - 31) 1997 Modelled IHME
23 (17 - 31) 1996 Modelled IHME
24 (17 - 31) 1995 Modelled IHME
24 (17 - 31) 1994 Modelled IHME
24 (17 - 31) 1993 Modelled IHME
24 (17 - 31) 1992 Modelled IHME
24 (17 - 32) 1991 Modelled IHME
24 (16 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
15 (10 - 23) 2013 Survey/reported Larney S et al, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.4 (%)
2019
(0.34 - 0.46(%))
IHME
HCV (RNA/cAg+)
2.06 (%)
2019
(1.68 - 2.51(%))
IHME

Survey/surveillance

No data available
HCV (anti-HCV)
2.3 (%)
2014
(1.3 - 4.2(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
108
2019
(73 - 149)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
226
2019
(154 - 317)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.04 (%)
2019, latest modelled
(0.03 - 0.05(%))
IHME

Prevalence PWID

HCV
78.40 (%)
2015, survey/surveillance
(73.50 - 82.80(%))
Abadie R et al, 2016

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
15
2013
(10 - 23)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources